BackOmeros Overview

Omeros Intangible Assets

Latest intangible assets for OMER: $0.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00

Peer average

Loading

Omeros Intangible Assets History

Loading

Omeros vs. peers: Intangible Assets Comparison

Loading

Omeros Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Omeros (OMER) FAQ

The latest intangible assets for OMER is $0 as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Omeros's historical trend and sector peers before judging valuation or financial health.

Over the past year, OMER's intangible assets moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Omeros's operating scale or balance-sheet position.

A intangible assets figure of $0 for OMER is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting OMER's intangible assets ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Omeros's intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.